The US health regulator has issued an Establishment Inspection Report (EIR) to Shilpa Medicare for its manufacturing facilities located at Raichur in Karnataka. Shilpa Medicare...
The US health regulator has provided its approval to Alembic Pharmaceuticals for generic Fluoxetine Hydrochloride tablets that are used in treating depression and panic disorder....
The US health regulator has issued an import alert on Divis Laboratories Visakhapatnam unit-II. Divis Laboratories has said in a statement that “The United States...
The US Food and Drug Administration has provided its final approval to the Aurobindo Pharma Ltd for manufacturing Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30...
Glenmark has got the establishment inspection report (EIR) from the US health regulator on closure of inspection of its Ankleshwar plant in Gujarat. It has...
Dr Reddy’s Laboratories has got 13 observations from the US health regulator for its formulation manufacturing facility at Duwada, Vishakhapatnam. Dr Redd’s Laboratories has said...
Cadila Healthcare said that it has received three observations from USFDA for its formulation facility at Baddi, Himachal Pradesh. From February 20 to March 1,...
The Establishment Inspection Report (EIR) has been received by the drug firm Panacea Biotec from the US health regulator after successful inspection of its manufacturing...